TABLE 3.

Serum biochemical parameter tests at termination.

	TG (mmol/L)	TCHO (mmol/L)	LDL-C (mmol/L)	HDL-C (mmol/L)	FPG (mmol/L)	FINS (mU/L)	HOMA-IR
CON-S	0.49 ± 0.06	3.32 ± 0.36	1.29 ± 0.23	2.66 ± 0.88	4.32 ± 0.59	15.37 ± 2.21	2.94 ± 0.53
CON-PA1	0.44 ± 0.04	3.13 ± 0.26	1.15 ± 0.16	2.89 ± 0.37	3.67 ± 0.60	14.34 ± 2.26	2.33 ± 0.49
CON-PA2	0.31 ± 0.04	3.01 ± 0.19*	1.02 ± 0.14*	3.41 ± 0.72*	3.65 ± 0.63	17.00 ± 3.20	2.81 ± 0.86
HFD-S	0.60 ± 0.07*	4.23 ± 0.31*	1.73 ± 0.27*	2.56 ± 0.08	5.73 ± 0.64**	19.48 ± 1.25**	4.95 ± 0.43**
HFD-PA1	0.43 ± 0.08	3.99 ± 0.33	1.62 ± 0.15	2.74 ± 0.47	4.35 ± 0.63##	18.63 ± 1.33##	3.60 ± 0.60##
HFD-PA2	0.38 ± 0.07#	3.67 ± 0.14#	1.46 ± 0.09	3.38 ± 0.52#	4.10 ± 0.80##Δ	15.79 ± 3.12##	2.79 ± 0.20##ΔΔ

TG, triglyceride; TCHO, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FPG, fasting plasma glucose; FINS, fasting serum insulin; HOMA-IR, homeostasis model assessment of insulin resistance. Compared with the CON-S group, *P < 0.05 and **P < 0.01; compared with the HFD-S group, ^#P < 0.05 and ^##P < 0.01; comparison between exercise groups (CON-PA1 vs. CON-PA2, HFD-PA1 vs. HFD-PA2), ^ΔP < 0.05 and ^ΔΔP < 0.01.